Top Markets
#1 Siren Siren +30.45%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +26.06%
#3 OriginTrail OriginTrail +21.43%
#4 DogBull DogBull +14.01%
#5 MarsCoin MarsCoin +12.76%
#6 COTI COTI +9.75%
#7 Xphere Xphere +6.05%
#8 Concordium Concordium +6.00%
#9 PulseChain PulseChain +5.89%
#10 Pons Pons +5.77%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Cutia Therapeutics Cutia Therapeutics

Cutia Therapeutics

2487
Rank in Stocks #22318
Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a... Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a robust dermatology platform for addressing conditions affecting both the skin and scalp. Its comprehensive therapeutic scope encompasses various dermatological challenges, including medications for localized fat accumulation, advanced care for scalp disorders, treatments for a wide array of skin ailments, and topical pain management. Founded in 2019, the company's main headquarters are situated in Shanghai, China, complemented by additional offices located in Beijing, Wuxi, and Hong Kong.
Share Price
$0.24945615
Last synced: 2026-08-21
Market Cap
$90.64M
Change (1 day)
-10.14%
Change (1 year)
-79.61%
Country
CN
Trade Cutia Therapeutics (2487)

Category

Healthcare
P/E ratio for Cutia Therapeutics (2487)
P/E ratio as of 2026 TTM: 0
According to Cutia Therapeutics latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Cutia Therapeutics from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.